Literature DB >> 17882275

Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women?

A Ponholzer1, C Temml, M Rauchenwald, M Marszalek, S Madersbacher.   

Abstract

Despite of the high prevalence, pathogenesis of female sexual dysfunction (FSD) is still poorly understood. A consecutive series of sexually active women underwent a health investigation and completed a questionnaire on FSD. Metabolic syndrome (MS) was defined according to the International Diabetes Federation definition. A total of 538 women with a mean age of 44 years (range: 30-69) was analysed. The premenopausal group comprised 329 women (61.2%) with a mean age of 38.5 years; the postmenopausal cohort contained 209 women (38.8%) with a mean age of 52.7 years. In the total cohort (n=538) MS was present in 17.6%, 8.5% in the premenopausal group and 32.6% in the postmenopausal women. In premenopausal women, the MS was an independent risk factor for impaired sexual desire (P=0.03) with an age-adjusted odds ratio of 3.3 (95% confidence interval: 1.5-7.3). In premenopausal female sexual life, the MS represents an independent role via its correlation to impaired desire.

Entities:  

Mesh:

Year:  2007        PMID: 17882275     DOI: 10.1038/sj.ijir.3901605

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  18 in total

1.  Assessment of female sexual function in a group of uncircumcised obese Egyptian women.

Authors:  A R M Elnashar; N H Ibrahim; H-Eh Ahmed; A M Hassanin; M A Elgawady
Journal:  Int J Impot Res       Date:  2015-07-09       Impact factor: 2.896

2.  Female sexual dysfunction in androgenetic alopecia: Case-control study.

Authors:  Eyup Burak Sancak; Sevilay Oguz; Tugba Akbulut; Aysegul Uludag; Alpaslan Akbas; Omer Kurt; Mehmet Fatih Akbulut
Journal:  Can Urol Assoc J       Date:  2016-07-12       Impact factor: 1.862

3.  Sexual intimacy in couples is associated with longer telomere length.

Authors:  Tomás Cabeza de Baca; Elissa S Epel; Theodore F Robles; Michael Coccia; Amanda Gilbert; Eli Puterman; Aric A Prather
Journal:  Psychoneuroendocrinology       Date:  2017-03-25       Impact factor: 4.905

Review 4.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

5.  Metabolic Syndrome and Sexual Function in Postmenopausal Women.

Authors:  Susan E Trompeter; Ricki Bettencourt; Elizabeth Barrett-Connor
Journal:  Am J Med       Date:  2016-04-29       Impact factor: 4.965

6.  Association Between Body Mass Index and Female Sexual Dysfunction: A Cross-sectional Study from the Data Registry on Experiences of Aging, Menopause, and Sexuality.

Authors:  Stephanie S Faubion; Flavia Fairbanks; Carol L Kuhle; Richa Sood; Juliana M Kling; Jennifer A Vencill; Kristin C Mara; Ekta Kapoor
Journal:  J Sex Med       Date:  2020-08-06       Impact factor: 3.802

Review 7.  The Impact of Metabolic Syndrome and Its Components on Female Sexual Dysfunction: A Narrative Mini-Review.

Authors:  Simona Di Francesco; Marika Caruso; Iole Robuffo; Andrea Militello; Elena Toniato
Journal:  Curr Urol       Date:  2019-03-08

8.  Interactions between inflammation and female sexual desire and arousal function.

Authors:  Tierney K Lorenz
Journal:  Curr Sex Health Rep       Date:  2019-10-28

9.  Metabolic syndrome and menopause.

Authors:  Zahra Jouyandeh; Farnaz Nayebzadeh; Mostafa Qorbani; Mojgan Asadi
Journal:  J Diabetes Metab Disord       Date:  2013-01-03

10.  Fecundability in reproductive aged women at risk of sexual dysfunction and associated risk factors: a prospective preconception cohort study.

Authors:  Tse Yeun Tan; Jerry Kok Yen Chan; See Ling Loy; Chee Wai Ku; Yin Bun Cheung; Keith M Godfrey; Yap-Seng Chong; Lynette Pei-Chi Shek; Kok Hian Tan; Fabian Kok Peng Yap; Jonathan Y Bernard; Helen Chen; Shiao-Yng Chan
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-25       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.